TimeScale Financial’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $690 | Hold |
300
| – | – | ﹤0.01% | 560 |
|
|
2023
Q1 | $909 | Hold |
300
| – | – | ﹤0.01% | 539 |
|
|
2022
Q4 | $573 | Hold |
300
| – | – | ﹤0.01% | 532 |
|
|
2022
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 478 |
|
|
2022
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 447 |
|
|
2022
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 469 |
|
|
2021
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 465 |
|
|
2021
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 456 |
|
|
2021
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 457 |
|
|
2021
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 451 |
|
|
2020
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 391 |
|
|
2020
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 413 |
|
|
2020
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 405 |
|
|
2020
Q1 | $0 | Hold |
300
| – | – | ﹤0.01% | 404 |
|
|
2019
Q4 | $0 | Hold |
300
| – | – | ﹤0.01% | 503 |
|
|
2019
Q3 | $0 | Hold |
300
| – | – | ﹤0.01% | 494 |
|
|
2019
Q2 | $1K | Buy |
+300
| New | +$1K | ﹤0.01% | 467 |
|